One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

Former Voivod frontman Eric Forrest shares his stage three prostate cancer fight and vows: "I'm gonna beat this parasite!" ...

As Candel Therapeutics gears up for a planned U.S. approval push for its prostate cancer drug later this year, RTW ...

For patients with mCRPC with bone metastases, the addition of radium-223 to enzalutamide therapy is associated with improved overall survival.

RTW committed $100M in U.S. launch funding, subject to U.S. Food and Drug Administration (FDA) approval of aglatimagene ...

AbCellera Biologics Inc. (NASDAQ: ABCL) Q4 2025 Earnings Call Transcript February 24, 2026 AbCellera Biologics Inc. beats ...

Swole — without the serious side effects. For generations, gym rats have turned to illicit steroid use for bigger muscles, despite the numerous side effects and dangerous risks, from roid rage and ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Worldwide revenue of $406.8 million and $1.54 billion for the fourth quarter and full year 2025GAAP fully diluted earnings per share of $0.82 and ...

If you’ve been feeling a little low in more than one aspect of life, you’re not alone, and chances are you’re not going crazy, either. You may be experiencing the symptoms of low testosterone.

Researchers at Case Western Reserve University have discovered a way to breach one of cancer's most stubborn defenses: the impenetrable fortress that solid tumors build around themselves.